Medicure Inc

NGQ1

Company Profile

  • Business description

    Medicure Inc is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market and sales to the Retail Public of pharmaceutical products. The Company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and increasing its e-commerce and mail order pharmaceutical business. The Company operates under two segments: the marketing and distribution of commercial products and the operation of a retail and mail order pharmacy. It generates the majority of its revenue from the Retail and Mail Order Pharmacy segment.

  • Contact

    1250 Waverley Street
    No. 2
    WinnipegMBR3T 6C6
    CAN

    T: +1 204 487-7412

    E: [email protected]

    https://www.medicure.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    22

Stocks News & Analysis

stocks

Expanding store network for ASX listed retailer

Sales growth but lack of margin expansion due to competition.
stocks

3 cheap fully franked stocks

Discounted Aussie shares that offer a tax rebate.
stocks

SpaceX jumps 19% in debut, but hurdles lie ahead

Pre-IPO holders could start selling later this summer, and earnings will be an important test.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,093.8034.300.38%
CAC 408,384.0133.140.40%
DAX 4024,894.01258.711.05%
Dow JONES (US)51,671.03468.770.92%
FTSE 10010,430.6241.10-0.39%
HKSE24,589.86252.81-1.02%
NASDAQ26,683.94795.103.07%
Nikkei 22569,148.60168.90-0.24%
NZX 50 Index13,386.6526.060.20%
S&P 5007,554.29122.831.65%
S&P/ASX 2008,879.6039.200.44%
SSE Composite Index4,087.369.11-0.22%

Market Movers